Skip to content
HomeMedia CenterPress releases FinancialJohnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference

Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference

Share Article
share to

New Brunswick, NJ (August 2nd, 2022) -- Johnson & Johnson (NYSE: JNJ) will participate in the 2022 Wells Fargo Securities Healthcare Conference at the Encore Boston Harbor in Everett, MA on Wednesday, September 7th. Ashley McEvoy, Executive Vice President, Worldwide Chairman, MedTech will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time).

This conference call will be available to investors and other interested parties by visiting the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately 48 hours after the live webcast.

###

Press Contacts:
Rachel Hooper
rhooper@its.jnj.com

Investor Contacts:
Sarah Wood
(732) 524-2617

You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.